By Allison Cerra

Drugmaker Teva has announced the availability of a generic version of Mirapex to treat the signs and symptoms of idiopathic Parkinson’s disease.

Pramipexole diHCl tablets are available in a 0.125-mg strength, in a bottle size of 63, and in 0.25-mg, 0.5-mg, 1-mg, and 1.5-mg strengths, in bottle sizes of 90. The generic is equivalent to Mirapex, which was developed by Boehringer Ingelheim Pharmaceuticals.

“Our customers count on Teva for a continuous supply of new generic products,” said Maureen Cavanaugh, VP customer operations and marketing. “With the launch of pramipexole dihydrochloride tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”